Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$385.71 +0.19%

+$0.70 today

Market cap
$46.32B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 4.06M

Average 1.72M

HUM Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Humana Inc.NYSE: HUM

Net Receivables · Q3 FY2026 · quarter ended Sep 2026

Net receivables rises 6.7% from a year ago

Net receivables stood at $2.87B at the end of Q3 FY2026, up 6.7% from a year earlier and down 49.7% from the prior quarter. Over 3 fiscal years it compounded at +25.0% a year.

Context

  • Net receivables amounted to 5.0% of total assets at the end of Q3 FY2026, down 0.4 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +6.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.87B-49.7% QoQ
Last fiscal yearDec 2025
$3.27B+20.9% YoY
Year agoSep 2025
$2.68B+6.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.7%——
1 year+20.9%——
3-year CAGR+25.0%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
3.27B USD
Year-over-year change
+20.9%
4-year CAGR
+15.9%

Net Receivables vs competitors

How HUM compares with its peers on the latest reported figures

  • HUM's Sep 2026 net receivables of $2.87B is the 7th highest of the 9 companies compared; the peer median is $19.31B.
  • Its year-over-year change of +6.7% is the 3rd highest of 9, against a peer median of -2.6%.
  • Net receivables amounts to 5.0% of total assets for HUM, versus a peer median of 19.6%.
HUM Competitors Peer median
Net Receivables for HUM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CVSCVS Health CorporationJun 2026$40.31B -0.8%+13.4%15.9%
CICigna CorporationSep 2026$31.49B -0.7%+19.2%20.0%
ELVElevance Health Inc.Sep 2026$24.57B +67.7%+9.1%19.2%
UNHUnitedHealth Group IncorporatedSep 2026$20.54B -62.9%+20.1%6.6%
CNCCentene CorporationJun 2026$18.08B -16.1%+10.9%21.8%
MOHMolina Healthcare, Inc.Sep 2026$3.36B -4.4%+15.3%21.5%
HUMHumana Inc.Sep 2026$2.87B +6.7%+25.0%5.0%
OSCROscar Health, Inc.Jun 2026$380.06M -49.0%-27.5%3.4%
ALHCAlignment Healthcare, Inc.Mar 2026$277.68M +29.7%+39.7%22.0%
Peer median (excluding HUM) $19.31B-2.6%+14.4%19.6%

Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents3.39B5.06B4.69B2.22B4.2B
Short-term Investments00000
Net Receivables1.81B1.67B2.04B2.7B3.27B
Inventory00000
Other Current Assets00000
Total Current Assets5.21B6.74B6.73B4.93B7.47B
Property, Plant & Equipment (Net)3.75B3.74B3.54B2.98B2.72B
Goodwill11.09B9.14B9.55B9.63B9.69B
Intangible Assets2.64B1.77B1.69B1.44B1.13B
Long-term Investments14.11B15.01B17.75B19.33B16.83B
Tax Assets578M851M48M260M84M
Other Non-current Assets7.37B6.49B7.58B7.74B10.83B
Total Non-current Assets39.54B36.99B40.16B41.39B41.28B
Total Assets44.75B43.73B46.89B46.31B48.75B
Account Payables8.1B9.08B10.07B10.27B9.81B
Short-term Debt2.14B2.26B1.61B724M150M
Tax Payables00000
Deferred Revenue254M286M266M260M356M
Other Current Liabilities00000
Total Current Liabilities10.49B11.63B11.95B11.26B10.31B
Long-term Debt10.54B9.03B10.21B11.14B12.37B
Deferred Tax Liabilities1.28B878M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.79B6.36B7.97B7.07B7.91B
Total Non-current Liabilities18.15B16.72B18.63B18.61B20.7B
Total Liabilities28.65B28.36B30.57B29.87B31.01B
Common Stock33M33M33M33M33M
Retained Earnings23.09B25.49B27.54B28.32B29.08B
Accumulated OCI42M(1.3B)(999M)(1.07B)(633M)
Other Stockholders Equity00000
Minority Interest23M59M56M70M80M
Total Equity16.1B15.37B16.32B16.45B17.74B
Total Debt13.23B11.75B12.27B12.26B12.94B
Net Debt9.83B6.69B7.58B10.04B8.74B

Humana Inc.

NYSE:HUM

Intrinsic Alpha fair value

Locked

Current Price

$385.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.